Related Experiment Video
Updated: Jan 8, 2026
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Effective Osteoporosis Treatment by Polypeptosome-Mediated Neutralization of Acid Bone Microenvironment
Jingjing Jiang1, Danqing Liu2, Xue Zhou3
1Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.
Abstract:
The acidification of the bone microenvironment is recognized as a key contributor to osteoporosis. However, current treatment approaches mainly rely on drugs to inhibit osteoclast activity, which often leads to systemic toxicity. Unlike conventional drug-based interventions, we present a polypeptosome (P1:1) that enables "drug-free" osteoporosis treatment by modulating the bone microenvironment. P1:1 was coassembled from poly(ε-caprolactone)37-block-poly(tyrosine)30-block-poly[lysine5-stat-(lysine-zoledronic acid)10] (PCL37-b-PTyr30-b-P[Lys5-stat-(Lys-ZOL)10]) and poly(ethylene oxide)23-block-poly(ε-caprolactone)26 (PEO23-b-PCL26) at a mass ratio of 1:1. The zoledronic acid (ZOL) group endows the polypeptosome with efficient bone-targeting capabilities with a hydroxyapatite (HA) binding rate of 75.3%, while the alkaline polylysine and antioxidant tyrosine segments synergistically restore bone microenvironment homeostasis through pH neutralization and ROS scavenging. In vivo, P1:1 regulates the bone microenvironment by downregulating pH-related genes (including Atp6v0d1) and oxidative stress markers such as lipid peroxidation (LPO) and malondialdehyde (MDA), thus enhancing the bone strength in OVX rats. Transcriptome sequencing further elucidates its therapeutic mechanisms. Overall, P1:1 restores bone microenvironment balance by regulating pH and ROS levels, thereby providing both a therapeutic approach for osteoporosis and insights into bone diseases.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Related Concept Videos
01:40Bone Remodeling
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Osteoclasts in Bone Remodeling
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...